期刊文献+

中药配合西医三联疗法治疗十二指肠球部溃疡89例疗效观察

Clinical Effect of Chinese Medicine with Western Medicine Triple Therapy on the Treatment of 89 Duodenal Ulcer Patients
下载PDF
导出
摘要 目的:观察中药配合西医三联疗法(雷贝拉唑联合阿莫西林、克拉霉素)治疗十二指肠球部溃疡的临床疗效。方法:将176例十二指肠球部溃疡患者随机分为2组,治疗组89例采用中药(甘草、白芍、半夏、黄连、桂枝、当归、丹参、延胡索、海螵蛸、三七等)配合西医三联疗法治疗;对照组89例单予西医三联疗法治疗,停药4周后复查胃镜及14碳一尿素呼气试验(14 CUBT),观察溃疡愈合情况以及幽门螺杆菌根除率。结果:治疗组及对照组幽门螺杆菌根除率及十二指肠球部溃疡愈合率分别为98.9%、88.8%和96.7%、85.7%。2组比较有显著性差异(P<0.05)。结论:中药配合西医三联疗法治疗十二指肠溃疡疗效较好。 Objective:To observe the clinical effect of traditional Chinese medicine with Western medicine triple therapy(rabeprazole combined amoxicillin,clarithromycin) on the treatment of duodenal ulcer patients.Methods: 176 patients with duodenal ulcer were randomly divided into 2 groups.89 patients in the treatment group were treated with Chinese herbs(Licorice root,white peony root,Pinellia,berberine,Gui,Angelica sinensis,Salvia,Corydalis,cuttlebone,Panax.etc.) combined with Western triple therapy whereas the 89 patients in the control group were simply with Western triple therapy.A review of endoscopy and 14 C urea breath test(14 CVBT) was conducted to observe Ulcer healing and Helicobacter pylori eradication rate 4 weeks after drug withdrawal.Results: The helicobacter pylori eradication rates and duodenal ulcer healing rates of the treatment group and the control group were 98.9%,88.8% and 96.7%,85.7% respectively.The comparison of 2 groups showed significant difference(P<0.05).Conclusion: The traditional Chinese medicine combined the western triple therapy has a better effect on the duodenal ulcer patients.
作者 王嫱 王敏
出处 《云南中医中药杂志》 2011年第4期19-20,100,共2页 Yunnan Journal of Traditional Chinese Medicine and Materia Medica
关键词 十二指肠球部溃疡 中药 三联疗法 duodenal ulcer Chinese Herbs triple therapy
  • 相关文献

参考文献5

二级参考文献31

  • 1王绪霖,缴稳玲,吕宗舜,杨恕,陈桂芳.抑制幽门螺旋菌中药的初步筛选[J].中国中西医结合杂志,1994,14(9):534-536. 被引量:351
  • 2赵飞,张建中,曾浔.新视角——质子泵抑制剂及其体外抑制幽门螺杆菌作用研究进展[J].中国全科医学,2005,8(11):936-938. 被引量:24
  • 3胡友莹,胡联华,王克霞,张荣波.丽珠胃三联根除慢性胃炎和消化性溃疡幽门螺杆菌感染的研究[J].中国基层医药,2006,13(10):1601-1602. 被引量:8
  • 4梁小燕,高青.质子泵抑制剂的研发进展[J].医学综述,2007,13(4):245-247. 被引量:22
  • 5中华医学会.第二届全国幽门螺杆菌专题学术研究会关于幽门螺杆蓖若干问题的意见[J].胃肠病学和肝病杂志,1997,6(2):190-190.
  • 6Besancon M,Simon A,Sachs G, et al. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents[J]. J Biol Chem,1997,272(22) :438-446.
  • 7Hirai M, Azuma T, l to S, et al, A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori[J]. J Gastroenterol, 1995,30(4) :61 - 64.
  • 8Hokari K, Sugiyama T, Kato M, et al. Efficacy of triple therapy with raheprazole for Helicohacter pylori infection and CYP2C19 genetic polymorphisism [ J ]. Aliment Phar macol Ther, 2001, 15 (14) :79- 84.
  • 9Malfertheiner P, Megraud F, O' Morain C, et al. Current concepts in the management of Helicobacter pylori infection:the Maastrieht 2- 2000 Consensus Report [ J ]. Aliment Pharmaeol Ther, 2002, 16 (2):167- 180.
  • 10Murakami K, Kimoto M. Antibiotic resistant H. pylori strains in the last ten years in Japan[J]. Nippon Rinsho,1999,57(5):81 -86.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部